CRITICAL CARE in OB, PART 3: Recognizing and responding to peripartum cardiomyopathy

Article

Cardiomyopathy is rare in patients who are at or near term, but it can be deadly. Consider the possibility in any woman who is pregnant or who has recently delivered and complains of swelling and trouble breathing.

Case presentation

One week postpartum, one of your patients calls to report that her leg swelling has gotten significantly worse over the past several days. Mrs. Smith is a 32-year-old Caucasian G2P2 who delivered twins by cesarean section at 38 weeks' gestation. She admits to being short of breath and fatigued, but attributes the symptoms to having two newborns. Evaluation in the office later that day reveals significant pitting edema extending to her thighs. Her initial blood pressure is 164/92, pulse 104 and regular, respiratory rate 22, oxygen saturation 91%. Crackles are audible in her lung bases and heart sounds are distant. You are concerned about peripartum cardiomyopathy and decide to admit Mrs. Smith to the hospital for further work-up.

Identifying peripartum cardiomyopathy

Fortunately, PPCM is rare, occurring in only one in 3,000 to 4,000 live births. Risk factors for PPCM include multiparity, advanced maternal age, multifetal gestation, preeclampsia, hypertension, preexisting cardiac disease, and use of tocolytics. Historically, mortality rates have been reported as high as 56%, but more recent studies suggest the real number may be closer to 9%.2,3 Despite this, PPCM accounts for 8% of all maternal deaths and is one of the few causes of maternal mortality that is on the rise.2,4 Forty-eight percent of patients who succumb to PPCM will die in the first 6 weeks postpartum. Fifty percent of PPCM deaths occur within a year after delivery.3 Being African-American increases a woman's risk of death from PPCM more than sixfold.3

Science has yet to definitively determine the etiology of peripartum cardiomyopathy. The most current available evidence suggests that viral myocarditis may be the underlying cause. One study reported endomyocardial biopsies consistent with myocarditis in 76% of patients with PPCM.5 The altered immune response in pregnancy also is believed to play a role in PPCM development by allowing greater viral replication. Evidence of autoantibodies against cardiac tissue proteins in patients with PPCM lends further credence to this hypothesis.

Mrs. Smith goes to the hospital

Recent Videos
How advancements in IVF are impacting embryologist workload and patient care | Image Credit: fertility.coopersurgical.com/our_experts
Study finds no causal link between maternal health in pregnancy and autism risk | Image Credit: med.nyu.edu/faculty.
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Medical experts personalize contraceptive options for complex cases | Image Credit: findcare.ahn.org
Related Content
© 2025 MJH Life Sciences

All rights reserved.